Showing results (671-680 of 1,188) with videos related to
Sort By:
Pageof 119
American Journal of Hematology|July 19, 2020
Phase I/II study of dasatinib in combination with decitabine in patients with accelerated or blast phase chronic myeloid leukemiaYasmin Abaza, Hagop Kantarjian, Yasmin Alwash, et al.Cancer|June 1, 2019
Unrecognized fluid overload during induction therapy increases morbidity in patients with acute promyelocytic leukemiaKamal Chamoun, Hagop M Kantarjian, Xuemei Wang, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 17, 2018
Secondary Philadelphia chromosome acquired during therapy of acute leukemia and myelodysplastic syndromeHabibe Kurt, Lan Zheng, Hagop M Kantarjian, et al.Cancer|December 22, 2017
Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phaseKoji Sasaki, Hagop Kantarjian, Susan O'Brien, et al.American Journal of Hematology|May 29, 2015
Bone marrow necrosis in acute leukemia: Clinical characteristic and outcomeTalha Badar, Aditya Shetty, Carlos Bueso-Ramos, et al.Blood Advances|January 21, 2022
Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVADNaveen Pemmaraju, Nathaniel R Wilson, Guillermo Garcia-Manero, et al.Cancer|March 26, 2003
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemiaApostolia M Tsimberidou, Hagop M Kantarjian, Jorge Cortes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Adaptive randomized study of idarubicin and cytarabine versus troxacitabine and cytarabine versus troxacitabine and idarubicin in untreated patients 50 years or older with adverse karyotype acute myeloid leukemiaFrancis J Giles, Hagop M Kantarjian, Jorge E Cortes, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2012
Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remissionBetul Oran, Uday Popat, Gabriella Rondon, et al.Malaria Journal|April 27, 2016
Increasing outdoor host-seeking in Anopheles gambiae over 6 years of vector control on Bioko IslandJacob I Meyers, Sharmila Pathikonda, Zachary R Popkin-Hall, et al.Pageof 119